Di Nuzzo Private Wealth, Inc. Exact Sciences Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $700 Million
- Q4 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 13 shares of EXAS stock, worth $871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 11
18.18%
Holding current value
$871
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EXAS
# of Institutions
679Shares Held
164MCall Options Held
2.12MPut Options Held
1.69M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.19 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.1MShares$1.08 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$809 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.33MShares$357 Million0.05% of portfolio
-
State Street Corp Boston, MA5.2MShares$348 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...